Climb Global Solutions vs ScanSource
CLMB and SCSC side by side, both in professional and commercial equipment and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CLMB and SCSC compare
Climb Global Solutions and ScanSource are about the same size, with market caps of $804M and $892M.
On earnings, ScanSource is cheaper: it trades at 13.9× trailing earnings, against 33.4× for Climb Global Solutions.
Climb Global Solutions grew revenue faster over the last twelve months (24.2% versus 14.8% for ScanSource).
Climb Global Solutions keeps more of each dollar of sales as profit, with a net margin of 3.1% compared with 2.0% at ScanSource.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CLMB | SCSC |
|---|---|---|
| Size and price | ||
| Market cap | $804M | $892M |
| Share price | $43.09 | $44.26 |
| Change, 1 year | 61.0% | 8.9% |
| Change, 5 years | 451% | 31.5% |
| Beta (5Y) | 0.85 | 1.15 |
| Employees | 412 | 2,100 |
| StockData Score | ||
| Total score | 14 | 14 |
| Valuation score | 0 | 4 (better) |
| Growth score | 3 (better) | 2 |
| Performance score | 5 (better) | 2 |
| Health score | 6 | 6 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 33.4× | 13.9× (better) |
| P/S | 1.0× | 0.3× (better) |
| P/B | 6.0× | 1.0× (better) |
| EV/EBITDA | 18.9× | 8.7× (better) |
| P/FCF | – | 18.2× |
| PEG | 1.84 (better) | 14.87 |
| FCF yield | – | 5.5% |
| Fair value | $24.56 | $57.78 |
| Margin of safety | −75.5% | 23.4% (better) |
| Growth | ||
| Revenue growth (TTM) | 24.2% (better) | 14.8% |
| Revenue growth, 5Y average | 21.0% (better) | 0.47% |
| Net income growth (TTM) | 11.4% (better) | −9.1% |
| EPS growth (TTM) | 11.2% (better) | −0.62% |
| EPS growth, 5Y average | 35.7% | 54.0% (better) |
| Profitability | ||
| Gross margin | 15.5% (better) | 13.0% |
| Operating margin | 4.0% (better) | 2.5% |
| Net margin | 3.1% (better) | 2.0% |
| FCF margin | – | 1.4% |
| Return on equity | 19.5% (better) | 7.4% |
| Return on invested capital | 35.8% (better) | 6.9% |
| Financial health | ||
| Debt / equity | 0.00 | 0.11 (better) |
| Net debt / EBITDA | −1.72 | 0.50 (better) |
| Interest coverage | – | 11.0× |
| Current ratio | 1.14 | 1.75 (better) |
| Altman Z-score | 3.34 (better) | 3.07 |
| Piotroski F-score | 5 | 8 (better) |
| Dividends and buybacks | ||
| Dividend yield | 0.00% | – |
| Payout ratio | 3.3% | – |
| Years of dividend growth | 0 | – |
| Dividend growth, 5Y average | 0.00% | – |
| Buyback yield | 0.27% | 9.1% (better) |
| Shareholder yield | 0.27% | 9.1% (better) |
| Ownership | ||
| Held by institutions | 80.1% | 107% |
| Held by insiders | 4.7% | 3.1% |
| Insider net buying, 12 months | −$609K (better) | −$7.2M |
| Short interest, % of float | 6.0% | 6.9% |
Go deeper
- CLMB stock overview
- CLMB income statement
- CLMB valuation and score
- SCSC stock overview
- SCSC income statement
- SCSC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.